Roy H. Larsen

3.8k citations

81 papers · 2.9k indexed · h-index 32

Radiology, Nuclear Medicine and Imaging top 0.5%
- Radiopharmaceutical Chemistry and Applications 73
- Medical Imaging Techniques and Applications 24
- Monoclonal and Polyclonal Antibodies Research 12
Pulmonary and Respiratory Medicine top 1%
- Radiation Therapy and Dosimetry 13
- Medical Imaging and Pathology Studies 13
- Prostate Cancer Treatment and Research 9
Radiation top 2%
Oncology top 5%
- Bone health and treatments 9
Inorganic Chemistry top 10%
Pathology and Forensic Medicine
- Lymphoma Diagnosis and Treatment 11

Co-authors: Øyvind S. Bruland Gjermund Henriksen Darrell R. Fisher Michael R. Zalutsky Sten Nilsson Jostein Dahle P. Hoff Asta Juzeniene
Cited by: Radiology, Nuclear Medicine and Imaging Pulmonary and Respiratory Medicine Radiation
Journals: Blood (4 papers)PLoS ONE (4 papers)Cancer Research (1 paper)
Partner nations: Norway United States Sweden

In The Last Decade

Roy H. Larsen

80 papers receiving 2.9k citations

Peers

Countries citing papers authored by Roy H. Larsen

Since Specialization

Citations

This map shows the geographic impact of Roy H. Larsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roy H. Larsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roy H. Larsen more than expected).

Fields of papers citing papers by Roy H. Larsen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roy H. Larsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roy H. Larsen. The network helps show where Roy H. Larsen may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Roy H. Larsen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Roy H. Larsen Line = papers co-authored together Roy H. Larsen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	First-in-Human Phase 0 Study of AB001, a Prostate-Specific Membrane Antigen–Targeted²¹²Pb Radioligand, in Patients with Metastatic Castration-Resistant Prostate Cancer Journal of Nuclear Medicine ·Kjetil Berner,Eivor Hernes,Monika Kvassheim,Mona-Elisabeth Revheim,Julie Bastiansen,Silje Selboe,Curtis L. Bakken,Simen Rykkje Grønningsæter,Øyvind S. Bruland,Roy H. Larsen,L. Bouzelmat,Vicki Jardine,Caroline Stokke	2025	6
2	Eighteen‐Months Safety and Efficacy Following Intraperitoneal Treatment With ²²⁴Radium‐Labeled Microparticles After CRS‐HIPEC in Patients With Peritoneal Metastasis From Colorectal Cancer Journal of Surgical Oncology ·Stein Gunnar Larsen,W. Graf,Roy H. Larsen,Mona Elisabeth Revheim,A. M. Mariathasan,Olaf Sørensen,Milan Spasojevic,Gloria Rashid,Nadja Lundstrøm,Trine Jensen Gjertsen,Anne-Kirsti Aksnes,Øyvind S. Bruland	2024	1
3	Factors Influencing the Therapeutic Efficacy of the PSMA Targeting Radioligand 212Pb-NG001 Cancers ·Vilde Yuli Stenberg,Anna Julie Kjøl Tornes,Hogne Røed Nilsen,Mona‐Elisabeth Revheim,Øyvind S. Bruland,Roy H. Larsen,Asta Juzeniene	2022	17
4	Targeted alpha therapy with the 224Ra/212Pb-TCMC-TP-3 dual alpha solution in a multicellular tumor spheroid model of osteosarcoma Frontiers in Medicine ·Anna Julie Kjøl Tornes,Vilde Yuli Stenberg,Roy H. Larsen,Øyvind S. Bruland,Mona-Elisabeth Revheim,Asta Juzeniene	2022	9
5	Evaluation of the PSMA-Binding Ligand 212Pb-NG001 in Multicellular Tumour Spheroid and Mouse Models of Prostate Cancer International Journal of Molecular Sciences ·Vilde Yuli Stenberg,Roy H. Larsen,Liwei Ma,Qian Peng,Petras Juzenas,Øyvind S. Bruland,Asta Juzeniene	2021	31
6	203/212Pb Theranostic Radiopharmaceuticals for Image-guided Radionuclide Therapy for Cancer Current Medicinal Chemistry ·Mengshi Li,Edwin A. Sagastume,Dongyoul Lee,Daniel R. McAlister,Anthony J. DeGraffenreid,Keith R. Olewine,Stephen A. Graves,Roy Copping,Saed Mirzadeh,Brian E. Zimmerman,Roy H. Larsen,Frances L. Johnson,Michael K. Schultz	2020	37
7	Calibration of sodium iodide detectors and reentrant ionization chambers for 212Pb activity in different geometries by HPGe activity determined samples Applied Radiation and Isotopes ·Elisa Napoli,Vilde Yuli Stenberg,Asta Juzeniene,Gro E. Hjellum,Øyvind S. Bruland,Roy H. Larsen	2020	19
8	Antitumor Activity of Novel Bone-seeking, α-emitting 224Ra-solution in a Breast Cancer Skeletal Metastases Model Anticancer Research ·Asta Juzeniene,Jenni Bernoulli,Mari I. Suominen,Jussi M. Halleen,Roy H. Larsen	2018	25
9	Preparation of 212 Pb-labeled monoclonal antibody using a novel 224 Ra-based generator solution Nuclear Medicine and Biology ·Sara Westrøm,Roman Generalov,Tina Bjørnlund Bønsdorff,Roy H. Larsen	2017	37
10	Biodistribution and Dosimetry of 177Lu-tetulomab, a New Radioimmunoconjugate for Treatment of Non-Hodgkin Lymphoma Current Radiopharmaceuticals ·Ada H. V. Repetto‐Llamazares,Roy H. Larsen,Camilla Mollatt,Michael Laßmann,Jostein Dahle	2013	33
11	Assessment of long-term radiotoxicity after treatment with the low-dose-rate alpha-particle-emitting radioimmunoconjugate 227Th-rituximab European Journal of Nuclear Medicine and Molecular Imaging ·Jostein Dahle,Thora J. Jónasdóttir,Helèn Heyerdahl,Jahn M. Nesland,Jørgen Borrebæk,Anne Kristine Hjelmerud,Roy H. Larsen	2009	35
12	Relative Biologic Effects of Low-Dose-Rate α-Emitting 227Th-Rituximab and β-Emitting 90Y-Tiuexetan-Ibritumomab Versus External Beam X-Radiation International Journal of Radiation OncologyBiologyPhysics ·Jostein Dahle,Øyvind S. Bruland,Roy H. Larsen	2008	30
13	Evaluation of the Binding of Radiolabeled Rituximab to CD20-Positive Lymphoma Cells: An In Vitro Feasibility Study Concerning Low-Dose-Rate Radioimmunotherapy with the α -Emitter ²²⁷ Th Cancer Biotherapy and Radiopharmaceuticals ·Katrine B. Melhus,Roy H. Larsen,Trond Stokke,Olav Kaalhus,Pål Kristian Selbo,Jostein Dahle	2007	15
14	Preparation of TH ²²⁷ -Labeled Radioimmunoconjugates, Assessment of Serum Stability and Antigen Binding Ability Cancer Biotherapy and Radiopharmaceuticals ·Roy H. Larsen,Jørgen Borrebæk,Jostein Dahle,Katrine B. Melhus,Cecilie Krogh,Miriam H. Valan,Øyvind S. Bruland	2007	42
15	Sterically stabilized liposomes as a carrier for α-emitting radium and actinium radionuclides Nuclear Medicine and Biology ·Gjermund Henriksen,Bent W. Schoultz,Terje E. Michaelsen,Øyvind S. Bruland,Roy H. Larsen	2004	79
16	Evaluation of potential chelating agents for radium Applied Radiation and Isotopes ·Gjermund Henriksen,P. Hoff,Roy H. Larsen	2002	72
17	Demonstration of highly specific toxicity of the α-emitting radioimmunoconjugate 211At-rituximab against non-Hodgkin's lymphoma cells British Journal of Cancer ·E Aurlien,Roy H. Larsen,Gunnar Kvalheim,Øyvind S. Bruland	2000	32
18	Influence of pretreatment with 3-amino-1-hydroxypropylidene-1,1-bisphosphonate (APB) on organ uptake of 211At and 125I-labeled amidobisphosphonates in mice Nuclear Medicine and Biology ·Kristin M Murud,Roy H. Larsen,Øyvind S. Bruland,P. Hoff	1999	14
19	Tissue distribution and radiation dosimetry of astatine-211-labeled chimeric 81C6, an α-particle-emitting immunoconjugate Nuclear Medicine and Biology ·Michael R. Zalutsky,Michael G. Stabin,Roy H. Larsen,Darell D. Bigner	1997	47
20	Evaluation of an internal cyclotron target for the production of 211At via the 209Bi (α,2n)211At reaction Applied Radiation and Isotopes ·Roy H. Larsen,Bruce W. Wieland,Michael R. Zalutsky	1996	89

About Roy H. Larsen

Roy H. Larsen is a scholar working on Radiology, Nuclear Medicine and Imaging, Radiation and Pulmonary and Respiratory Medicine, having authored 81 papers that have together received 2.9k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (73 papers), Medical Imaging Techniques and Applications (24 papers), Radiation Therapy and Dosimetry (13 papers), Medical Imaging and Pathology Studies (13 papers), Monoclonal and Polyclonal Antibodies Research (12 papers), Lymphoma Diagnosis and Treatment (11 papers), Bone health and treatments (9 papers) and Prostate Cancer Treatment and Research (9 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (2.5k citations), Pulmonary and Respiratory Medicine (1.5k citations) and Radiation (356 citations). Roy H. Larsen has collaborated with scholars based in Norway, United States and Sweden. Frequent co-authors include Øyvind S. Bruland, Gjermund Henriksen, Darrell R. Fisher, Michael R. Zalutsky, Sten Nilsson, Jostein Dahle, P. Hoff, Asta Juzeniene, Jørgen Borrebæk and Knut Breistøl. Their work appears in journals such as Blood, PLoS ONE and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact